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Table. National epidemiological characteristics of Enterobacteriaceae with KPC carbapenemases  1	  













Infection Control interventions 
at the National level 
Country of origin of 
KPC isolates 
Co-production of  
KPC with other 
carbapenemases in 






K pneumoniae ST258 Hospital Yes Yes, toolkit for hospital and regional 




-Minimizing and optimizing the use of 
devices 
-Patient and staff cohorting 
-Screening cultures in a selected 
population at high risk 
-Antimicrobial stewardship 
-Laboratory notification of positive 
cases 
Originated in the US1 No 
Canada 2008  K pneumoniae ST-258 
ST-512 
Hospital None reported At the provincial level, including:  





























None reported Regional interventions through 
surveillance networks:  
-Antibiotic stewardship 
-Molecular characterization and typing 
of carbapenem-resistant 
Enterobacteriaceae  










Hospital None reported No Imported cases not 
described 
No 














UK 2003 K pneumoniae 
(mostly; first 
isolate in 2007) 
E. coli (first 
isolate in 2010), 
Enterobacter 
spp. (first 











Hospital None reported Yes,8 including: 
-Cohorting patients 
-Single rooms for carriers 
-Equipment disinfection 
-Hand hygiene 
-Active screening of contacts 
-Terminal cleaning 
-Cohorting staff 
-Enhance communication between 
healthcare providers 
-Track readmission of carriers 
Greece, Cyprus, Israel, 
Curaçao 9-11; but most 
cases now reflect domestic 
spread 
Single K. pneumoniae 
with KPC and VIM 
enzymes. 
Ireland 2009 K pneumoniae ST-258 Hospital None reported Yes.12 including: 
-Surveillance cultures to occur in high 
risk patients  
- KPCs are reportable 
-Single room and contact precautions 
-Consider cohorting staff 
Imported cases not 
described 
 No 
Spain 2009 K pneumoniae 






Hospital None reported No Imported cases not 
described 
 No 
France 2005 K pneumoniae ST258 Hospital None Yes,15,15 including:  




NYC, US 2005 16 
NYC, US, 2005 17 
Greece, 2008 18 
India, 2011 19 
Italy, 2010 20 
No 




unit 21  
No Unclear if came from a 
colonized Israeli physician 
22 
VIM 23  
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Yes Yes24, including:  
- At the hospital level: contact 
precautions, hand hygiene, 
microbiological surveillance,  
- requirement to notify and send 
suspected isolates to the local Sanitary-
Epidemiological Inspectorate which 
then notifies the Chief Sanitary 
Inspector 
  
Index case not known, 
then mostly in-country 
transmissions. Sporadic 
imports from US, NYC 25 
and Italy (not published 
yet) 
No 
Hungary 2008 K pneumoniae ST258 
ST11 
Hospital No No Index case came from 








K pneumoniae ST258 Hospital  Yes Yes, including:  
-Hand hygiene promotion 
-Active surveillance cultures among 
high risk patients 
-Contact precautions 
-Isolation or cohorting positive patients 
-Communication between hospitals and 
health authorities 
Not documented VIM-1, VIM-4 
Israel  2005 K pneumoniae ST-258 Hospital Yes Yes,27 including:  
-Mandatory reporting of CRE positive 
patients (daily census) 
-Task force in charge of intervening in 
hospital outbreaks 
-Contact isolation in single rooms 
-Cohorting of positive patients and staff 
-Readmissions were placed again in 
isolation 
-Rectal surveillance cultures 
-Infection control intervention in 
LTCFs110. 
Index case presumably 






K pneumoniae ST-258 Hospital No No Finland: Greece, Italy and 
USA 28  
Sweden: Greece 29 
No 
India 2002 (exact 
year is 
unclear) 


















None Yes, including:  
-Infection Control guidelines  
-Antibiotic stewardship program 
(underway) 
-Enhancing the national antimicrobial 
resistance monitoring system 
surveillance 
-Promoting appropriate antibiotic use in 
veterinary medicine 








K pneumoniae ST258 Hospital No Yes, including: 
-Standard infection control precautions 
- Antimicrobial stewardship  
-Community based antimicrobial 
prescribing 
- Education of stakeholders 
-Surveillance cultures patients directly 
transferred from an overseas hospital or 
exposed to overseas hospital in the last 
12 months 
-Notify facility infection control staff of 
suspected/proven KPC production. 
Greece, Israel None 
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